These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
480 related articles for article (PubMed ID: 36069578)
1. Broad-Spectrum Inhibitors against Class A, B, and C Type β-Lactamases to Block the Hydrolysis against Antibiotics: Kinetics and Structural Characterization. Farhat N; Gupta D; Ali A; Kumar Y; Akhtar F; Kulanthaivel S; Mishra P; Khan F; Khan AU Microbiol Spectr; 2022 Oct; 10(5):e0045022. PubMed ID: 36069578 [TBL] [Abstract][Full Text] [Related]
3. Metallo-β-lactamase inhibitors: A continuing challenge for combating antibiotic resistance. Kang SJ; Kim DH; Lee BJ Biophys Chem; 2024 Jun; 309():107228. PubMed ID: 38552402 [TBL] [Abstract][Full Text] [Related]
4. Chemically synthesised flavone and coumarin based isoxazole derivatives as broad spectrum inhibitors of serine β-lactamases and metallo-β-lactamases: a computational, biophysical and biochemical study. Farhat N; Ali A; Waheed M; Gupta D; Khan AU J Biomol Struct Dyn; 2023; 41(13):5990-6000. PubMed ID: 35848348 [TBL] [Abstract][Full Text] [Related]
5. 1,4,7-Triazacyclononane Restores the Activity of β-Lactam Antibiotics against Metallo-β-Lactamase-Producing Somboro AM; Amoako DG; Osei Sekyere J; Kumalo HM; Khan R; Bester LA; Essack SY Appl Environ Microbiol; 2019 Feb; 85(3):. PubMed ID: 30478231 [TBL] [Abstract][Full Text] [Related]
6. Lomovskaya O; Castanheira M; Lindley J; Rubio-Aparicio D; Nelson K; Tsivkovski R; Sun D; Totrov M; Loutit J; Dudley M Antimicrob Agents Chemother; 2023 Nov; 67(11):e0044023. PubMed ID: 37800963 [TBL] [Abstract][Full Text] [Related]
7. Activity of aztreonam in combination with novel β-lactamase inhibitors against metallo-β-lactamase-producing Enterobacterales from Spain. Vázquez-Ucha JC; Alonso-Garcia I; Guijarro-Sánchez P; Lasarte-Monterrubio C; Álvarez-Fraga L; Cendón-Esteve A; Outeda M; Maceiras R; Peña-Escolano A; Martínez-Guitián M; Arca-Suárez J; Bou G; Beceiro A; Int J Antimicrob Agents; 2023 Apr; 61(4):106738. PubMed ID: 36736925 [TBL] [Abstract][Full Text] [Related]
8. Metallo-β-Lactamase Inhibitors Inspired on Snapshots from the Catalytic Mechanism. Palacios AR; Rossi MA; Mahler GS; Vila AJ Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32503337 [TBL] [Abstract][Full Text] [Related]
9. VNRX-5133 (Taniborbactam), a Broad-Spectrum Inhibitor of Serine- and Metallo-β-Lactamases, Restores Activity of Cefepime in Hamrick JC; Docquier JD; Uehara T; Myers CL; Six DA; Chatwin CL; John KJ; Vernacchio SF; Cusick SM; Trout REL; Pozzi C; De Luca F; Benvenuti M; Mangani S; Liu B; Jackson RW; Moeck G; Xerri L; Burns CJ; Pevear DC; Daigle DM Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31871094 [TBL] [Abstract][Full Text] [Related]
10. Recent advances in β-lactamase inhibitor chemotypes and inhibition modes. Li R; Chen X; Zhou C; Dai QQ; Yang L Eur J Med Chem; 2022 Nov; 242():114677. PubMed ID: 35988449 [TBL] [Abstract][Full Text] [Related]
11. Metallo-β-lactamase-mediated antimicrobial resistance and progress in inhibitor discovery. Yang Y; Yan YH; Schofield CJ; McNally A; Zong Z; Li GB Trends Microbiol; 2023 Jul; 31(7):735-748. PubMed ID: 36858862 [TBL] [Abstract][Full Text] [Related]
12. Progress toward inhibitors of metallo-β-lactamases. McGeary RP; Tan DT; Schenk G Future Med Chem; 2017 May; 9(7):673-691. PubMed ID: 28504895 [TBL] [Abstract][Full Text] [Related]
13. Designing of inhibitors against CTX-M-15 type β-lactamase: potential drug candidate against β-lactamases-producing multi-drug-resistant bacteria. Ali A; Danishuddin ; Maryam L; Srivastava G; Sharma A; Khan AU J Biomol Struct Dyn; 2018 May; 36(7):1806-1821. PubMed ID: 28545327 [TBL] [Abstract][Full Text] [Related]
14. In vitro efficacy of imipenem-relebactam and cefepime-AAI101 against a global collection of ESBL-positive and carbapenemase-producing Enterobacteriaceae. Tselepis L; Langley GW; Aboklaish AF; Widlake E; Jackson DE; Walsh TR; Schofield CJ; Brem J; Tyrrell JM Int J Antimicrob Agents; 2020 Jul; 56(1):105925. PubMed ID: 32084512 [TBL] [Abstract][Full Text] [Related]
15. Theaflavin-3,3´-digallate increases the antibacterial activity of β-lactam antibiotics by inhibiting metallo-β-lactamase activity. Teng Z; Guo Y; Liu X; Zhang J; Niu X; Yu Q; Deng X; Wang J J Cell Mol Med; 2019 Oct; 23(10):6955-6964. PubMed ID: 31392792 [TBL] [Abstract][Full Text] [Related]
16. Studies on the inhibition of AmpC and other β-lactamases by cyclic boronates. Cahill ST; Tyrrell JM; Navratilova IH; Calvopiña K; Robinson SW; Lohans CT; McDonough MA; Cain R; Fishwick CWG; Avison MB; Walsh TR; Schofield CJ; Brem J Biochim Biophys Acta Gen Subj; 2019 Apr; 1863(4):742-748. PubMed ID: 30738906 [TBL] [Abstract][Full Text] [Related]
17. Diversity and Proliferation of Metallo-β-Lactamases: a Clarion Call for Clinically Effective Metallo-β-Lactamase Inhibitors. Somboro AM; Osei Sekyere J; Amoako DG; Essack SY; Bester LA Appl Environ Microbiol; 2018 Sep; 84(18):. PubMed ID: 30006399 [TBL] [Abstract][Full Text] [Related]